HU228780B1 - Use of interleukin-18 inhibitors to inhibit tumor metastasis - Google Patents

Use of interleukin-18 inhibitors to inhibit tumor metastasis Download PDF

Info

Publication number
HU228780B1
HU228780B1 HU0202107A HUP0202107A HU228780B1 HU 228780 B1 HU228780 B1 HU 228780B1 HU 0202107 A HU0202107 A HU 0202107A HU P0202107 A HUP0202107 A HU P0202107A HU 228780 B1 HU228780 B1 HU 228780B1
Authority
HU
Hungary
Prior art keywords
tree
tree tree
cells
tel
species
Prior art date
Application number
HU0202107A
Other languages
English (en)
Hungarian (hu)
Inventor
Charles Dinarello
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of HUP0202107A2 publication Critical patent/HUP0202107A2/hu
Publication of HUP0202107A3 publication Critical patent/HUP0202107A3/hu
Publication of HU228780B1 publication Critical patent/HU228780B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0202107A 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis HU228780B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors
PCT/IL2000/000419 WO2001007480A2 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Publications (3)

Publication Number Publication Date
HUP0202107A2 HUP0202107A2 (en) 2002-10-28
HUP0202107A3 HUP0202107A3 (en) 2005-01-28
HU228780B1 true HU228780B1 (en) 2013-05-28

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202107A HU228780B1 (en) 1999-07-22 2000-07-17 Use of interleukin-18 inhibitors to inhibit tumor metastasis

Country Status (31)

Country Link
US (1) US7741276B2 (enExample)
EP (1) EP1206274B1 (enExample)
JP (1) JP4827352B2 (enExample)
KR (1) KR100682219B1 (enExample)
CN (1) CN1173736C (enExample)
AR (1) AR024907A1 (enExample)
AT (1) ATE363288T1 (enExample)
AU (1) AU782478B2 (enExample)
BG (1) BG65800B1 (enExample)
BR (1) BR0012675A (enExample)
CA (1) CA2380216C (enExample)
CY (1) CY1107932T1 (enExample)
CZ (1) CZ302114B6 (enExample)
DE (2) DE60035049T2 (enExample)
DK (1) DK1206274T3 (enExample)
EA (1) EA005419B1 (enExample)
EE (1) EE04838B1 (enExample)
ES (1) ES2186596T3 (enExample)
HK (1) HK1048248B (enExample)
HU (1) HU228780B1 (enExample)
IL (2) IL131047A0 (enExample)
MX (1) MXPA02000838A (enExample)
NO (1) NO329827B1 (enExample)
NZ (1) NZ516535A (enExample)
PL (1) PL202477B1 (enExample)
PT (1) PT1206274E (enExample)
SK (1) SK287522B6 (enExample)
TR (1) TR200200169T2 (enExample)
UA (1) UA73745C2 (enExample)
WO (1) WO2001007480A2 (enExample)
ZA (1) ZA200200390B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL356836A1 (en) 2000-02-10 2004-07-12 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
AU1174402A (en) 2000-10-11 2002-04-22 Viron Therapeutics Inc Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
CN100556450C (zh) * 2001-05-16 2009-11-04 耶达研究发展有限公司 Il-18抑制剂在治疗或预防脓毒症中的应用
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
US7279155B2 (en) * 2002-10-08 2007-10-09 Ares Trading S.A. Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
ES2385639T3 (es) 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
AU2006256763B2 (en) 2005-06-10 2012-08-02 Ares Trading S.A. Process for the purification of IL-18 binding protein
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
AU2023236289A1 (en) 2022-03-15 2024-08-15 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
JP2026503273A (ja) 2023-01-06 2026-01-28 ラッセン・セラピューティクス・インコーポレイテッド 抗ｉｌ－１８ｂｐ抗体
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT69922A (en) * 1992-09-02 1995-09-28 Isis Pharmaceuticals Inc Oligonucleotide modification of cell adhesion
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
WO1998041232A2 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
IL131047A0 (en) 2001-01-28
AU5843200A (en) 2001-02-13
KR20020027493A (ko) 2002-04-13
SK287522B6 (sk) 2011-01-04
ES2186596T1 (es) 2003-05-16
DE60035049T2 (de) 2007-09-27
NO329827B1 (no) 2011-01-03
DE60035049D1 (de) 2007-07-12
EP1206274A2 (en) 2002-05-22
HUP0202107A3 (en) 2005-01-28
MXPA02000838A (es) 2002-07-30
NZ516535A (en) 2004-04-30
BG65800B1 (bg) 2009-12-31
WO2001007480A2 (en) 2001-02-01
EE200200032A (et) 2003-02-17
US7741276B2 (en) 2010-06-22
JP2003505472A (ja) 2003-02-12
CA2380216C (en) 2012-01-31
DE1206274T1 (de) 2002-11-14
EP1206274B1 (en) 2007-05-30
ATE363288T1 (de) 2007-06-15
CA2380216A1 (en) 2001-02-01
NO20020153L (no) 2002-03-11
KR100682219B1 (ko) 2007-02-12
PL202477B1 (pl) 2009-06-30
EE04838B1 (et) 2007-06-15
EA200200189A1 (ru) 2002-12-26
IL147675A (en) 2009-05-04
CN1173736C (zh) 2004-11-03
CZ2002195A3 (cs) 2002-06-12
CY1107932T1 (el) 2013-09-04
BR0012675A (pt) 2002-04-09
AR024907A1 (es) 2002-10-30
HK1048248A1 (en) 2003-03-28
TR200200169T2 (tr) 2002-06-21
UA73745C2 (en) 2005-09-15
CN1364086A (zh) 2002-08-14
AU782478B2 (en) 2005-08-04
PL353732A1 (en) 2003-12-01
BRPI0012675B8 (enExample) 2021-05-25
EA005419B1 (ru) 2005-02-24
WO2001007480A3 (en) 2001-05-10
JP4827352B2 (ja) 2011-11-30
BRPI0012675B1 (pt) 2001-02-01
HUP0202107A2 (en) 2002-10-28
NO20020153D0 (no) 2002-01-11
DK1206274T3 (da) 2007-08-13
BG106311A (en) 2002-08-30
ES2186596T3 (es) 2007-11-16
SK882002A3 (en) 2002-07-02
PT1206274E (pt) 2007-07-06
ZA200200390B (en) 2003-04-30
US20080003216A1 (en) 2008-01-03
CZ302114B6 (cs) 2010-10-20
HK1048248B (zh) 2005-04-22

Similar Documents

Publication Publication Date Title
Chen et al. Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells
Alspach et al. Interferon γ and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity
Salamone et al. High level expression of bioactive recombinant human growth hormone in the milk of a cloned transgenic cow
Uematsu et al. Lipopolysaccharide-dependent prostaglandin E2 production is regulated by the glutathione-dependent prostaglandin E2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway
Ngo et al. Angiotensin-I converting enzyme inhibitory peptides from antihypertensive skate (Okamejei kenojei) skin gelatin hydrolysate in spontaneously hypertensive rats
JP5759557B2 (ja) 抗がん融合タンパク質
Hirano et al. A receptor-like kinase, related to cell wall sensor of higher plants, is required for sexual reproduction in the unicellular charophycean alga, Closterium peracerosum–strigosum–littorale complex
WO2022256500A3 (en) Dll3 targeting trispecific proteins and methods of use
EA025830B1 (ru) Слитый белок против злокачественной опухоли
US11041157B2 (en) Slit2D2-HSA fusion protein and use thereof against tumours
Wu et al. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein
Lin et al. Thrombin-induced CCAAT/enhancer-binding protein β activation and IL-8/CXCL8 expression via MEKK1, ERK, and p90 ribosomal S6 kinase 1 in lung epithelial cells
WO2022192675A1 (en) Synthetic signal peptides for directing secretion of heterologous proteins in yeast
Qian et al. Long-acting human interleukin 2 bioconjugate modified with fatty acids by sortase A
Han et al. Brazzein protein production in transgenic carrot cells using air-lift bioreactor culture
ES2393125T3 (es) Un método para estimular la angiogénesis usando DKK2 y composición que comprende la misma
CN112442129A (zh) 肿瘤酶响应型重组焦亡蛋白递药系统及其抗肿瘤用途
Yoo et al. STAMPing into mitochondria
CN106636047B (zh) 一种催化丙氨酸脱羧的蛋白质及其基因和应用
US7785838B2 (en) Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
Kraynyak et al. Plasmid-encoded interleukin-15 receptor α enhances specific immune responses induced by a DNA vaccine in vivo
CN109295081B (zh) 一种LDLR-Lamp2b融合基因、表达载体及其应用
CN103805621A (zh) 靶向性抗肿瘤融合蛋白质lpo的新型制备工艺
CN1860229A (zh) 一种具有抑癌作用的重组蛋白及其编码基因与应用
Tiefenthaler et al. M1204, a novel 2′, 5′ oligoadenylate synthetase with a ubiquitin-like extension, is induced during maturation of murine dendritic cells